# FDA 483 - Hugel Inc. - February 01, 2024

Source: https://www.globalkeysolutions.net/records/483/hugel-inc/6b694a3e-ecef-44c5-a2d4-8713fa0d0ef2

> FDA 483 for Hugel Inc. on February 01, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hugel Inc.
- Inspection Date: 2024-02-01
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2021-08-20](https://www.globalkeysolutions.net/records/483/hugel-inc/727c4a4e-fb4b-478b-a667-f03ab3670285)
- [483 - 2023-03-10](https://www.globalkeysolutions.net/records/483/hugel-inc/91aac001-2d80-4687-a620-be062477583c)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/hugel-inc/701d9c61-6fe6-4cc0-b046-fb7811f9f34f)
- [483 - 2021-08-20](https://www.globalkeysolutions.net/records/483/hugel-inc/21fcd217-7913-4979-9020-de9e0f5af888)
- [483 - 2023-03-10](https://www.globalkeysolutions.net/records/483/hugel-inc/6c14c4f0-05ab-40aa-bbdf-b4401687bf6e)

## Related Officers

- [Joao Pedras-Vasconcelos](https://www.globalkeysolutions.net/people/joao-pedras-vasconcelos/143cf25e-168d-43da-adc8-9107c4f01b44)
- [Richard Ledwidge](https://www.globalkeysolutions.net/people/richard-ledwidge/aaf4f089-8f7a-4d1f-b2e1-5f2e476a22a9)

Company: https://www.globalkeysolutions.net/companies/hugel-inc/c3f52dc8-7334-454e-b30b-24a21c659c7d

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd